These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 24735885)

  • 1. Effects of PYY3-36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men.
    Schmidt JB; Gregersen NT; Pedersen SD; Arentoft JL; Ritz C; Schwartz TW; Holst JJ; Astrup A; Sjödin A
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1248-56. PubMed ID: 24735885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study.
    Bergmann NC; Lund A; Gasbjerg LS; Meessen ECE; Andersen MM; Bergmann S; Hartmann B; Holst JJ; Jessen L; Christensen MB; Vilsbøll T; Knop FK
    Diabetologia; 2019 Apr; 62(4):665-675. PubMed ID: 30683945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects.
    Sloth B; Holst JJ; Flint A; Gregersen NT; Astrup A
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1062-8. PubMed ID: 17148749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appetite hormones and energy intake in obese men after consumption of fructose, glucose and whey protein beverages.
    Bowen J; Noakes M; Clifton PM
    Int J Obes (Lond); 2007 Nov; 31(11):1696-703. PubMed ID: 17593904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appetite regulation in overweight, sedentary men after different amounts of endurance exercise: a randomized controlled trial.
    Rosenkilde M; Reichkendler MH; Auerbach P; Toräng S; Gram AS; Ploug T; Holst JJ; Sjödin A; Stallknecht B
    J Appl Physiol (1985); 2013 Dec; 115(11):1599-609. PubMed ID: 24052035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.
    Flint A; Raben A; Ersbøll AK; Holst JJ; Astrup A
    Int J Obes Relat Metab Disord; 2001 Jun; 25(6):781-92. PubMed ID: 11439290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
    Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.
    Steinert RE; Schirra J; Meyer-Gerspach AC; Kienle P; Fischer H; Schulte F; Goeke B; Beglinger C
    Am J Clin Nutr; 2014 Aug; 100(2):514-23. PubMed ID: 24965303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
    Flint A; Raben A; Astrup A; Holst JJ
    J Clin Invest; 1998 Feb; 101(3):515-20. PubMed ID: 9449682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of exercise on gut peptides, energy intake and appetite.
    Martins C; Morgan LM; Bloom SR; Robertson MD
    J Endocrinol; 2007 May; 193(2):251-8. PubMed ID: 17470516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.
    Bagger JI; Holst JJ; Hartmann B; Andersen B; Knop FK; Vilsbøll T
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4541-52. PubMed ID: 26445112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No effect of physiological concentrations of glucagon-like peptide-2 on appetite and energy intake in normal weight subjects.
    Sørensen LB; Flint A; Raben A; Hartmann B; Holst JJ; Astrup A
    Int J Obes Relat Metab Disord; 2003 Apr; 27(4):450-6. PubMed ID: 12664078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
    Näslund E; Barkeling B; King N; Gutniak M; Blundell JE; Holst JJ; Rössner S; Hellström PM
    Int J Obes Relat Metab Disord; 1999 Mar; 23(3):304-11. PubMed ID: 10193877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes.
    Horowitz M; Flint A; Jones KL; Hindsberger C; Rasmussen MF; Kapitza C; Doran S; Jax T; Zdravkovic M; Chapman IM
    Diabetes Res Clin Pract; 2012 Aug; 97(2):258-66. PubMed ID: 22446097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of polydextrose with breakfast or with a midmorning preload on food intake and other appetite-related parameters in healthy normal-weight and overweight females: An acute, randomized, double-blind, placebo-controlled, and crossover study.
    Ibarra A; Olli K; Pasman W; Hendriks H; Alhoniemi E; Raza GS; Herzig KH; Tiihonen K
    Appetite; 2017 Mar; 110():15-24. PubMed ID: 27916475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males.
    Sloth B; Davidsen L; Holst JJ; Flint A; Astrup A
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E604-9. PubMed ID: 17566112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of postprandial profiles of ghrelin, active GLP-1, and total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety.
    Gibbons C; Caudwell P; Finlayson G; Webb DL; Hellström PM; Näslund E; Blundell JE
    J Clin Endocrinol Metab; 2013 May; 98(5):E847-55. PubMed ID: 23509106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats.
    Chelikani PK; Haver AC; Reidelberger RD
    Diabetes; 2006 Nov; 55(11):3038-46. PubMed ID: 17065340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects.
    Steinert RE; Poller B; Castelli MC; Drewe J; Beglinger C
    Am J Clin Nutr; 2010 Oct; 92(4):810-7. PubMed ID: 20720259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appetite regulatory hormone responses to various dietary proteins differ by body mass index status despite similar reductions in ad libitum energy intake.
    Bowen J; Noakes M; Clifton PM
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2913-9. PubMed ID: 16735482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.